Global Oral Vaccines Market Research Report 2021

    • ID: AR3013825
    • 03 February, 2021
    • Other
    • Region: Global
    • 124 Pages
    • QYResearch

    1 Oral Vaccines Market Overview

    • 1.1 Product Overview and Scope of Oral Vaccines
    • 1.2 Oral Vaccines Segment by Type
      • 1.2.1 Global Oral Vaccines Sales Growth Rate Comparison by Type (2021-2027)
      • 1.2.2 Rotavirus Vaccine
      • 1.2.3 Cholera Vaccine
      • 1.2.4 Oral Polio Vaccine
      • 1.2.5 Others
    • 1.3 Oral Vaccines Segment by Application
      • 1.3.1 Oral Vaccines Sales Comparison by Application: (2021-2027)
      • 1.3.2 Public
      • 1.3.3 Private
    • 1.4 Global Oral Vaccines Market Size Estimates and Forecasts
      • 1.4.1 Global Oral Vaccines Revenue 2016-2027
      • 1.4.2 Global Oral Vaccines Sales 2016-2027
      • 1.4.3 Oral Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

    2 Oral Vaccines Market Competition by Manufacturers

    • 2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2016-2021)
    • 2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2016-2021)
    • 2.3 Global Oral Vaccines Average Price by Manufacturers (2016-2021)
    • 2.4 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
    • 2.5 Oral Vaccines Market Competitive Situation and Trends
      • 2.5.1 Oral Vaccines Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
      • 2.5.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Oral Vaccines Retrospective Market Scenario by Region

    • 3.1 Global Oral Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
    • 3.2 Global Oral Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
    • 3.3 North America Oral Vaccines Market Facts & Figures by Country
      • 3.3.1 North America Oral Vaccines Sales by Country
      • 3.3.2 North America Oral Vaccines Revenue by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Oral Vaccines Market Facts & Figures by Country
      • 3.4.1 Europe Oral Vaccines Sales by Country
      • 3.4.2 Europe Oral Vaccines Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Oral Vaccines Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Oral Vaccines Sales by Region
      • 3.5.2 Asia Pacific Oral Vaccines Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Oral Vaccines Market Facts & Figures by Country
      • 3.6.1 Latin America Oral Vaccines Sales by Country
      • 3.6.2 Latin America Oral Vaccines Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Oral Vaccines Sales by Country
      • 3.7.2 Middle East and Africa Oral Vaccines Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Oral Vaccines Historic Market Analysis by Type

    • 4.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
    • 4.2 Global Oral Vaccines Revenue Market Share by Type (2016-2021)
    • 4.3 Global Oral Vaccines Price by Type (2016-2021)

    5 Global Oral Vaccines Historic Market Analysis by Application

    • 5.1 Global Oral Vaccines Sales Market Share by Application (2016-2021)
    • 5.2 Global Oral Vaccines Revenue Market Share by Application (2016-2021)
    • 5.3 Global Oral Vaccines Price by Application (2016-2021)

    6 Key Companies Profiled

    • 6.1 Merck
      • 6.1.1 Merck Corporation Information
      • 6.1.2 Merck Description and Business Overview
      • 6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.1.4 Merck Product Portfolio
      • 6.1.5 Merck Recent Developments/Updates
    • 6.2 GSK
      • 6.2.1 GSK Corporation Information
      • 6.2.2 GSK Description and Business Overview
      • 6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.2.4 GSK Product Portfolio
      • 6.2.5 GSK Recent Developments/Updates
    • 6.3 Sanofi
      • 6.3.1 Sanofi Corporation Information
      • 6.3.2 Sanofi Description and Business Overview
      • 6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.3.4 Sanofi Product Portfolio
      • 6.3.5 Sanofi Recent Developments/Updates
    • 6.4 Lanzhou Institute
      • 6.4.1 Lanzhou Institute Corporation Information
      • 6.4.2 Lanzhou Institute Description and Business Overview
      • 6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.4.4 Lanzhou Institute Product Portfolio
      • 6.4.5 Lanzhou Institute Recent Developments/Updates
    • 6.5 Serum Institute
      • 6.5.1 Serum Institute Corporation Information
      • 6.5.2 Serum Institute Description and Business Overview
      • 6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.5.4 Serum Institute Product Portfolio
      • 6.5.5 Serum Institute Recent Developments/Updates
    • 6.6 Valneva
      • 6.6.1 Valneva Corporation Information
      • 6.6.2 Valneva Description and Business Overview
      • 6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.6.4 Valneva Product Portfolio
      • 6.6.5 Valneva Recent Developments/Updates
    • 6.7 Shanghai United Cell
      • 6.6.1 Shanghai United Cell Corporation Information
      • 6.6.2 Shanghai United Cell Description and Business Overview
      • 6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.4.4 Shanghai United Cell Product Portfolio
      • 6.7.5 Shanghai United Cell Recent Developments/Updates
    • 6.8 Bibcol
      • 6.8.1 Bibcol Corporation Information
      • 6.8.2 Bibcol Description and Business Overview
      • 6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.8.4 Bibcol Product Portfolio
      • 6.8.5 Bibcol Recent Developments/Updates
    • 6.9 PaxVax
      • 6.9.1 PaxVax Corporation Information
      • 6.9.2 PaxVax Description and Business Overview
      • 6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.9.4 PaxVax Product Portfolio
      • 6.9.5 PaxVax Recent Developments/Updates
    • 6.10 Vabiotech
      • 6.10.1 Vabiotech Corporation Information
      • 6.10.2 Vabiotech Description and Business Overview
      • 6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.10.4 Vabiotech Product Portfolio
      • 6.10.5 Vabiotech Recent Developments/Updates
    • 6.11 Tiantan Biological
      • 6.11.1 Tiantan Biological Corporation Information
      • 6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
      • 6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.11.4 Tiantan Biological Product Portfolio
      • 6.11.5 Tiantan Biological Recent Developments/Updates
    • 6.12 EuBiologics
      • 6.12.1 EuBiologics Corporation Information
      • 6.12.2 EuBiologics Oral Vaccines Description and Business Overview
      • 6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.12.4 EuBiologics Product Portfolio
      • 6.12.5 EuBiologics Recent Developments/Updates
    • 6.13 Panacea Biotec Ltd
      • 6.13.1 Panacea Biotec Ltd Corporation Information
      • 6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
      • 6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.13.4 Panacea Biotec Ltd Product Portfolio
      • 6.13.5 Panacea Biotec Ltd Recent Developments/Updates
    • 6.14 Bio-Med
      • 6.14.1 Bio-Med Corporation Information
      • 6.14.2 Bio-Med Oral Vaccines Description and Business Overview
      • 6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.14.4 Bio-Med Product Portfolio
      • 6.14.5 Bio-Med Recent Developments/Updates
    • 6.15 Halfkin Bio-Pharmaceuticals
      • 6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
      • 6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
      • 6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 6.15.4 Halfkin Bio-Pharmaceuticals Product Portfolio
      • 6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

    7 Oral Vaccines Manufacturing Cost Analysis

    • 7.1 Oral Vaccines Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Oral Vaccines
    • 7.4 Oral Vaccines Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Oral Vaccines Distributors List
    • 8.3 Oral Vaccines Customers

    9 Oral Vaccines Market Dynamics

    • 9.1 Oral Vaccines Industry Trends
    • 9.2 Oral Vaccines Growth Drivers
    • 9.3 Oral Vaccines Market Challenges
    • 9.4 Oral Vaccines Market Restraints

    10 Global Market Forecast

    • 10.1 Oral Vaccines Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Oral Vaccines by Type (2022-2027)
      • 10.1.2 Global Forecasted Revenue of Oral Vaccines by Type (2022-2027)
    • 10.2 Oral Vaccines Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Oral Vaccines by Application (2022-2027)
      • 10.2.2 Global Forecasted Revenue of Oral Vaccines by Application (2022-2027)
    • 10.3 Oral Vaccines Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Oral Vaccines by Region (2022-2027)
      • 10.3.2 Global Forecasted Revenue of Oral Vaccines by Region (2022-2027)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

      Segment by Type
      Rotavirus Vaccine
      Cholera Vaccine
      Oral Polio Vaccine
      Others

      Segment by Application
      Public
      Private

      By Region
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E

      By Company
      Merck
      GSK
      Sanofi
      Lanzhou Institute
      Serum Institute
      Valneva
      Shanghai United Cell
      Bibcol
      PaxVax
      Vabiotech
      Tiantan Biological
      EuBiologics
      Panacea Biotec Ltd
      Bio-Med
      Halfkin Bio-Pharmaceuticals



      Summary:
      Oral Vaccines Market Research Report is about Oral Vaccines Industry study. Get complete Oral Vaccines market research report published after Market Study, Industrial Analysis with Trends & Statistics. Oral Vaccines Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      Global Oral Vaccines Market Research Report 2021

      • 124 Pages
      • Region: Global
      $2,900.00

      Global Rotavirus Vaccines Market Research Report 2021

      • 91 Pages
      • Region: Global
      $2,900.00

      Global TB Vaccines Market Research Report 2021

      • 97 Pages
      • Region: Global
      $2,900.00

      Global Toxoid Vaccines Market Research Report 2021

      • 123 Pages
      • Region: Global
      $2,900.00

      Global RNA Vaccines Market Research Report 2021

      • 99 Pages
      • Region: Global
      $2,900.00